Simphotek is happy to announce a new addition to the Scientific Advisory Board, Abraham Wu, MD, a Harvard-educated radiation oncologist...

New Jersey Tech Weekly, Sep 30, 2020 – Suppose there is a therapy in development that could treat your internal solid tumors and...

Simphotek, Inc. has been selected as one of 20 company Finalist to pitch to Onelin Capital and 400+ global early-stage investors Onelin...

Simphotek, Inc, a leading edge biotech company, developing noninvasive personalized products for treating internal solid tumors, was...

Simphotek has been selected as one of the showcase companies for the 2020-2021 NCI SBIR Investor Initiatives. As a MedTech company, it...

Scientia, 2019 – Simphotek treatment planning and computational dosimetry software Dosie™ can be pivotal in widespread adaptation of...

International Photodynamic Association World Congress, 2019 (Boston, USA) – Simphotek announces a new addition to its simulation software...

SPIE BiOS, 2019 (Optical Methods for Tumor Treatment and Detection) – We introduce our Dosie modeling software that helps in predicting...

Cancers, 2017 (Special Issue: Photodynamic Cancer Therapy) – Treatment planning and real-time dosimetry optimize and further advance the...

Dr. Potasek presents at FRAC Workshop at National Cancer Institute, Rockville, MD.